Literature DB >> 9301579

Drug interactions: keeping it straight.

G D Anastasio1, K O Cornell, D Menscer.   

Abstract

Drug interactions are common causes of treatment failure and adverse reactions. Patients who have a number of chronic disorders, patients who take many medications or patients who have impaired renal function are at increased risk for these problems. Special attention must be given to drugs that require blood level monitoring, because these agents have a narrow margin of safety. Drug interactions are especially likely to occur with enzyme inhibitors such as erythromycin, cimetidine, ciprofloxacin and metronidazole. Mechanisms of drug interactions include problems with absorption secondary to binding by antacids or other cations, interference with the distribution of drugs secondary to the displacement of highly protein-bound drugs, differences in metabolism secondary to variability of the cytochrome P450 enzyme system, and interaction-related problems with drug excretion by renal tubules. Antagonistic and synergistic reactions also need to be considered. Finally, the time course in which a given drug interaction is likely to occur must be taken into account when deciding whether the interaction is responsible for an adverse effect or treatment failure.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9301579

Source DB:  PubMed          Journal:  Am Fam Physician        ISSN: 0002-838X            Impact factor:   3.292


  2 in total

Review 1.  Drug interactions of meglitinide antidiabetics involving CYP enzymes and OATP1B1 transporter.

Authors:  Naina Mohamed Pakkir Maideen; Gobinath Manavalan; Kumar Balasubramanian
Journal:  Ther Adv Endocrinol Metab       Date:  2018-04-06       Impact factor: 3.565

2.  Serious Drug-Drug Interactions in the Prescriptions of Diabetic Patients.

Authors:  Veintramuthu Sankar; Yousif Saaed; Rinku Mary Joseph; Hudson Azizi; Pinky Mariyam Thomas
Journal:  Med Sci (Basel)       Date:  2015-10-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.